Open AccessAspergillus Vertebral Osteomyelitis in Immunocompetent Hosts: Role of Triazole Antifungal Therapy
Author(s) -
Alex Studemeister,
D. A. Stevens
Publication year - 2010
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciq039
Subject(s) - medicine , voriconazole , aspergillosis , itraconazole , vertebral osteomyelitis , aspergillus fumigatus , surgery , aspergillus , antifungal , mycosis , osteomyelitis , dermatology , immunology , microbiology and biotechnology , biology
A review of published cases, in addition to a recently treated patient, is presented that describes the clinical features and outcomes of triazole therapy for vertebral aspergillosis in immunocompetent patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom